Anpario (LON:ANP) Receives “House Stock” Rating from Shore Capital Group

Shore Capital Group reaffirmed their house stock rating on shares of Anpario (LON:ANP) in a research report released on Monday,Digital Look reports.

Separately, Canaccord Genuity Group upgraded Anpario to a “buy” rating and upped their price objective for the stock from GBX 457 to GBX 570 in a research note on Thursday, April 2nd. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, Anpario currently has an average rating of “Buy” and an average target price of GBX 570.

Anpario Trading Up 1.9%

Shares of LON ANP opened at GBX 494 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 4.50 and a quick ratio of 5.16. The stock has a market capitalization of £83.71 million, a P/E ratio of 13.02 and a beta of 0.99. Anpario has a 1-year low of GBX 370 and a 1-year high of GBX 580. The business has a fifty day moving average price of GBX 488.17 and a 200 day moving average price of GBX 494.84.

Anpario announced that its Board of Directors has authorized a share repurchase program on Monday, April 27th that authorizes the company to buyback 0 shares. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.